Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer.
- DOI
- 10.1371/journal.pone.0356762
- Published
- 2026-08-24
- Container
- PLoS One
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1371/journal.pone.0356762,
title = {Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer.},
author = {Alzate D and Sánchez AY and Pacheco Y and Isaza Ruget M and Sánchez R and Castillo C and Parra-López CA.},
year = {2026},
journal = {PLoS One},
doi = {10.1371/journal.pone.0356762},
url = {https://doi.org/10.1371/journal.pone.0356762}
}RIS
TY - JOUR TI - Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer. AU - Alzate D AU - Sánchez AY AU - Pacheco Y AU - Isaza Ruget M AU - Sánchez R AU - Castillo C AU - Parra-López CA. PY - 2026 JO - PLoS One DO - 10.1371/journal.pone.0356762 UR - https://doi.org/10.1371/journal.pone.0356762 ER -
APA
D, A., AY, S., Y, P., M, I. R., R, S., C, C., & CA., P. (2026). Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer.. PLoS One. https://doi.org/10.1371/journal.pone.0356762
Source records
- europe-pmc · retrieved 2026-09-27T04:00:07.326Z